Resveratrol impedes the stemness, epithelial-mesenchymal transition, and metabolic reprogramming of cancer stem cells in nasopharyngeal carcinoma through p53 activation

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Shen, Yao An ^a   Lin, Chien Hung ^a   Chi, Wei Hsin ^a   Wang, Chia Yu ^a   Hsieh, Yi Tao ^a   Wei, Yau Huei ^a,b   Chen, Yann Jang ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b MACKAY MEDICAL COLLEGE   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 145; MICRORNA 200C; PROTEIN P53; REACTIVE OXYGEN METABOLITE; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CANCER THERAPY; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; INFORMATION; METASTASIS; MITOCHONDRIAL MEMBRANE; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; WOUND HEALING;

EID: 84877989716     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/590393     Document Type: Article

References (45)

1. Lo K. W., To K. F., Huang D. P., Focus on nasopharyngeal carcinoma. Cancer Cell 2004 5 5 423 428 2-s2.0-2442540470 10.1016/S1535-6108(04)00119-9 (Pubitemid 38612865)
2. Bensouda Y., Kaikani W., Ahbeddou N., Rahhali R., Jabri M., Mrabti H., Boussen H., Errihani H., Treatment for metastatic nasopharyngeal carcinoma. European Annals of Otorhinolaryngology, Head and Neck Diseases 2011 128 2 79 85 2-s2.0-79955479303 10.1016/j.anorl.2010.10.003
3. Mueller M. T., Hermann P. C., Heeschen C., Cancer stem cells as new therapeutic target to prevent tumour progression and metastasis. Frontiers in Bioscience 2010 2 602 613 2-s2.0-77954505691
4. Mani S. A., Guo W., Liao M. J., Eaton E. N., Ayyanan A., Zhou A. Y., Brooks M., Reinhard F., Zhang C. C., Shipitsin M., Campbell L. L., Polyak K., Brisken C., Yang J., Weinberg R. A., The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008 133 4 704 715 2-s2.0-43049165453 10.1016/j.cell.2008.03.027 (Pubitemid 351636299)
5. Ksiazkiewicz M., Markiewicz A., Zaczek A. J., Epithelial-mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells. Pathobiology 2012 79 4 195 208
6. Fong D., Yeh A., Naftalovich R., Choi T. H., Chan M. M., Curcumin inhibits the side population (SP) phenotype of the rat C6 glioma cell line: towards targeting of cancer stem cells with phytochemicals. Cancer Letters 2010 293 1 65 72 2-s2.0-77952420903 10.1016/j.canlet.2009.12.018
7. Tang S. N., Singh C., Nall D., Meeker D., Shankar S., Srivastava R. K., The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition. Journal of Molecular Signaling 2012 5, article 14 2-s2.0-77955641868 10.1186/1750-2187-5-14
8. Lin C. H., Shen Y. A., Hung P. H., Yu Y. B., Chen Y. J., Epigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines. BMC Complementary and Alternative Medicine 2012 12 201 1 12
9. Hu F. W., Tsai L. L., Yu C. H., Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment. Molecular Nutrition & Food Research 2012 56 8 1247 1258
10. Huang T. T., Lin H. C., Chen C. C., Lu C. C., Wei C. F., Wu T. S., Liu F. G., Lai H. C., Resveratrol induces apoptosis of human nasopharyngeal carcinoma cells via activation of multiple apoptotic pathways. Journal of Cellular Physiology 2011 226 3 720 728 2-s2.0-78650630361 10.1002/jcp.22391
11. Shankar S., Nall D., Tang S. N., Meeker D., Passarini J., Sharma J., Srivastava R. K., Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS ONE 2011 6 1 2-s2.0-79551617718 10.1371/journal.pone.0016530 e16530
12. Pandey P. R., Okuda H., Watabe M., Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Research and Treatment 2011 130 2 387 398
13. Yang Y. P., Chang Y. L., Huang P. I., Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis. Journal of Cellular Physiology 2011 227 3 976 993
14. Wang H., Zhang H., Tang L., Resveratrol inhibits TGF-beta1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Toxicology 2013 303 139 146
15. Vergara D., Valente C. M., Tinelli A., Siciliano C., Lorusso V., Acierno R., Giovinazzo G., Santino A., Storelli C., Maffia M., Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells. Cancer Letters 2011 310 1 1 8 2-s2.0-79961126482 10.1016/j.canlet.2011. 04.009
16. Lin C. T., Chan W. Y., Chen W., Huang H. M., Wu H. C., Hsu M. M., Chuang-S. M., Wang C. C., Characterization of seven newly established nasopharyngeal carcinoma cell lines. Laboratory Investigation 1993 68 6 716 727 2-s2.0-0027300987
17. Glaser R., Zhang H. Y., Yao K., Zhu H. C., Wang F. X., Li G. Y., Wen D. S., Li Y. P., Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proceedings of the National Academy of Sciences of the United States of America 1989 86 23 9524 9528 2-s2.0-0024332127 10.1073/pnas.86.23.9524 (Pubitemid 20010459)
18. Chang J. T. C., Chan S. H., Lin C. Y., Lin T. Y., Wang H. M., Liao C. T., Wang T. H., Lee L. Y., Cheng A. J., Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15. Molecular Cancer Therapeutics 2007 6 8 2271 2279 2-s2.0-34548067637 10.1158/1535-7163.MCT-06-0801 (Pubitemid 47294755)
19. Chen S. F., Chang Y. C., Nieh S., Nonadhesive culture system as a model of rapid sphere formation with cancer stem cell properties. PLoS ONE 2012 7 2 e31864
20. Wang J., Guo L. P., Chen L. Z., Zeng Y. X., Shih H. L., Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Research 2007 67 8 3716 3724 2-s2.0-34248529666 10.1158/0008-5472.CAN-06-4343 (Pubitemid 46762157)
21. Lin C. S., Lee H. T., Lee S. Y., High mitochondrial DNA copy number and bioenergetic function are associated with tumor invasion of esophageal squamous cell carcinoma cell lines. International Journal of Molecular Sciences 2012 13 9 11228 11246
22. Sethi S., Radio N. M., Kotlarczyk M. P., Chen C. T., Wei Y. H., Jockers R., Witt-Enderby P. A., Determination of the minimal melatonin exposure required to induce osteoblast differentiation from human mesenchymal stem cells and these effects on downstream signaling pathways. Journal of Pineal Research 2010 49 3 222 238 2-s2.0-77956325376 10.1111/j.1600-079X.2010.00784.x
23. Qian W., Van Houten B., Alterations in bioenergetics due to changes in mitochondrial DNA copy number. Methods 2010 51 4 452 457 2-s2.0-77955266829 10.1016/j.ymeth.2010.03.006
24. Warburg O., On the origin of cancer cells. Science 1956 123 3191 309 314 2-s2.0-12444279265
25. Prigione A., Fauler B., Lurz R., Lehrach H., Adjaye J., The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells 2010 28 4 721 733 2-s2.0-77951002352 10.1002/stem.404
26. Diehn M., Cho R. W., Lobo N. A., Kalisky T., Dorie M. J., Kulp A. N., Qian D., Lam J. S., Ailles L. E., Wong M., Joshua B., Kaplan M. J., Wapnir I., Dirbas F. M., Somlo G., Garberoglio C., Paz B., Shen J., Lau S. K., Quake S. R., Brown J. M., Weissman I. L., Clarke M. F., Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009 458 7239 780 783 2-s2.0-64749093574 10.1038/nature07733
27. Kuo P. L., Chiang L. C., Lin C. C., Resveratrol- induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sciences 2002 72 1 23 34 2-s2.0-0037159575 10.1016/S0024-3205(02)02177-X (Pubitemid 35291091)
28. Atten M. J., Godoy-Romero E., Attar B. M., Milson T., Zopel M., Holian O., Resveratrol regulates cellular PKC α and δ to inhibit growth and induce apoptosis in gastric cancer cells. Investigational New Drugs 2005 23 2 111 119 2-s2.0-15244347017 10.1007/s10637-005-5855-8 (Pubitemid 40386227)
29. Kao C. L., Huang P. I., Tsai P. H., Tsai M. L., Lo J. F., Lee Y. Y., Chen Y. J., Chen Y. W., Chiou S. H., Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor. International Journal of Radiation Oncology Biology Physics 2009 74 1 219 228 2-s2.0-64049084289 10.1016/j.ijrobp.2008.12.035
30. Yu L. J., Wu M. L., Li H., Chen X. Y., Wang Q., Sun Y., Kong Q. Y., Liu J., Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells. Neoplasia 2008 10 7 736 744 2-s2.0-45849113190 10.1593/neo.08304 (Pubitemid 351883890)
31. da Costa D. C. F., Casanova F. A., Quarti J., Transient transfection of a wild-type p53 gene triggers resveratrol-induced apoptosis in cancer cells. PLoS ONE 2012 7 11 e48746
32. Lin H., Xiong W., Zhang X., Liu B., Zhang W., Zhang Y., Cheng J., Huang H., Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells. Oncology Reports 2011 26 4 925 930 2-s2.0-79960815940 10.3892/or.2011.1380
33. Prabhu V. V., Allen J. E., Hong B., Therapeutic targeting of the p53 pathway in cancer stem cells. Expert Opinion Therapeutic Targets 2012 16 12 1161 1174
34. Ginestier C., Charafe-Jauffret E., Birnbaum D., p53 and cancer stem cells: the mevalonate connexion. Cell Cycle 2012 11 14 2583 2584
35. Hong H., Takahashi K., Ichisaka T., Aoi T., Kanagawa O., Nakagawa M., Okita K., Yamanaka S., Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009 460 7259 1132 1135 2-s2.0-69349100179 10.1038/nature08235
36. Li H., Collado M., Villasante A., Strati K., Ortega S., Cãamero M., Blasco M. A., Serrano M., The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009 460 7259 1136 1139 2-s2.0-69349103956 10.1038/nature08290
37. Kawamura T., Suzuki J., Wang Y. V., Menendez S., Morera L. B., Raya A., Wahl G. M., Belmonte J. C. I., Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009 460 7259 1140 1144 2-s2.0-69349100455 10.1038/nature08311
38. Utikal J., Polo J. M., Stadtfeld M., Maherali N., Kulalert W., Walsh R. M., Khalil A., Rheinwald J. G., Hochedlinger K., Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 2009 460 7259 1145 1148 2-s2.0-69349098273 10.1038/nature08285
39. Marión R. M., Strati K., Li H., Murga M., Blanco R., Ortega S., Fernandez-Capetillo O., Serrano M., Blasco M. A., A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009 460 7259 1149 1153 2-s2.0-69349094006 10.1038/nature08287
40. Wang S. P., Wang W. L., Chang Y. L., Wu C. T., Chao Y. C., Kao S. H., Yuan A., Lin C. W., Yang S. C., Chan W. K., Li K. C., Hong T. M., Yang P. C., p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nature Cell Biology 2009 11 6 694 704 2-s2.0-67349166210 10.1038/ncb1875
41. Sachdeva M., Zhu S., Wu F., Wu H., Walia V., Kumar S., Elble R., Watabe K., Mo Y. Y., p53 represses c-Myc through induction of the tumor suppressor miR-145. Proceedings of the National Academy of Sciences of the United States of America 2009 106 9 3207 3212 2-s2.0-62549148270 10.1073/pnas.0808042106
42. Liu C., Kelnar K., Liu B., Chen X., Calhoun-Davis T., Li H., Patrawala L., Yan H., Jeter C., Honorio S., Wiggins J. F., Bader A. G., Fagin R., Brown D., Tang D. G., The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nature Medicine 2011 17 2 211 215 2-s2.0-79751473114
43. Chang C. J., Chao C. H., Xia W., Yang J. Y., Xiong Y., Li C. W., Yu W. H., Rehman S. K., Hsu J. L., Lee H. H., Liu M., Chen C. T., Yu D., Hung M. C., P53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nature Cell Biology 2011 13 3 317 323 2-s2.0-79952283482 10.1038/ncb2173
44. Xu N., Papagiannakopoulos T., Pan G., Thomson J. A., Kosik K. S., MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 2009 137 4 647 658 2-s2.0-67349149082 10.1016/j.cell.2009.02.038
45. Chen H. C., Chen G. H., Chen Y. H., Liao W. L., Liu C. Y., Chang K. P., Chang Y. S., Chen S. J., MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. British Journal of Cancer 2009 100 6 1002 1011 2-s2.0-62549160416 10.1038/sj.bjc.6604948